Insider Shareholders with Direct Ownership of Sagimet Biosciences Inc. (SGMT)
This section provides a comprehensive overview of the insiders with direct ownership of Sagimet Biosciences Inc. (SGMT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Sagimet Biosciences Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
New Enterprise Associates 13 Lp
> 10% Shareholder |
3,850,937 | 888,338 | 3,000,275 | 3 |
Jan 29, 2024
Reduced 22.08%
|
|
David Happel
President & CEO |
755,200 | 65,478 | 689,722 | 6 |
Jul 21, 2025
Reduced 8.67%
|
|
Elizabeth Rozek
General Counsel and CCO |
205,420 | 21,694 | 183,726 | 4 |
Jul 21, 2025
Reduced 5.54%
|
|
George Kemble
Director |
156,380 | 37,687 | 118,693 | 4 |
Jul 23, 2024
Reduced 16.6%
|
|
Eduardo Bruno Martins
Chief Medical Officer |
123,570 | 16,634 | 106,936 | 4 |
Jul 21, 2025
Reduced 7.18%
|
|
Thierry Chauche
Chief Financial Officer |
17,000 | 0 | 17,000 | 1 |
Feb 06, 2025
Added 50.0%
|
|
Patrick J Kerins
> 10% Shareholder |
13,139 | 0 | 13,139 | 1 |
Jan 29, 2024
Added 50.0%
|
|
Merdad Parsey
Director |
12,794 | 8,677 | 12,794 | 2 |
Jul 18, 2023
Added 24.35%
|
|
Nea Partners 13, Limited Partnership
> 10% Shareholder |
260,950 | 260,950 | 0 | 2 |
Jan 29, 2024
Reduced 100.0%
|
|
Beth C Seidenberg
Director |
84,768 | 0 | 0 | 1 |
N/A
|